Rebecca Kay Bright, Author

  Integrating Prevention Levels: Enhancing NCD Surveillance Systems Developing surveillance systems for chronic or noncommunicable diseases (NCDs) requires a comprehensive understanding of prevention strategies across different levels. These strategies, encompassing primary, secondary, and tertiary prevention, serve as vital guiding principles in informing the design and implementation of effective surveillance systems. At the primary prevention level, which focuses on averting the onset of disease, surveillance systems should prioritize collecting population-wide data on risk factors and determinants of NCDs. By monitoring lifestyle habits, environmental exposures, and socio-economic factors, these systems can identify trends and patterns that inform targeted interventions to reduce the incidence of NCDs. Secondary prevention, aimed at early detection and treatment, emphasizes the importance of early diagnosis through screening programs. Surveillance systems can play a crucial role he

A&P can be a hard subject to master so I've collected some links etc of helpful information to help you learn this material. http://m.ivyroses.com/HumanBody/Skeletal/axial-and-appendicular-skeleton.php ((Powerpoints)) http://www.millerplace.k12.ny.us/webpages/cscott/index.cfm?subpage=1058407 https://www.slideshare.net/mobile/ammedicinemedicine/anatomy-physiology-lecture-notes-blood http://www.innerbody.com https://sites.google.com/site/ehsanatomyphysiologyaa/ http://www.cram.com/flashcards/anatomy-physiology-i-ch-4-histology-tissues-752278 http://kobiljak.msu.edu/CAI/Histology/HistologyTitle.htm http://anthro.palomar.edu/blood/blood_components.htm https://www.slideshare.net/mobile/SmartSciencePro/4-components-ofblood https://www.myvmc.com/anatomy/blood-function-and-composition/ http://learn.genetics.utah.edu/content/basics/ ~~~ I'll add more links and more info as it comes up. Tips: The biggest thing students ski

Understanding Hemophilia: A Journey through History and Science      Hemophilia, the oldest known hereditary bleeding disorder, has left an indelible mark on history. Its recognition was catapulted onto the world stage by none other than the grandson of Queen Victoria of England and heir to the Russian throne, Alexei, who suffered from a severe case in the early 1900s amidst the tumult of the Russian Revolution.      Today, we understand hemophilia as a complex condition characterized by defects in blood coagulation factors, leading to prolonged bleeding and a host of associated symptoms. With two main types, A and B (also known as Christmas Disease), hemophilia presents a spectrum of severity, from mild to moderate to severe, depending on the amount of clotting factors produced.      Despite its relatively low prevalence, hemophilia affects hundreds of children each year, with approximately 85% diagnosed with hemophilia A and 15% with hemophilia B. For those with severe hemophilia,